Bionaturis to create subsidiary in China
Bionaturis constuirá una filial en China
Intel ID : 226795
| Synopsis |
|
Spain-based Bionaturis (BME: BNT) reached an agreement with Administrative Committee for High Technology Industrial Development Zone in Jiangsu, to establish a subsidiary at the University Science and Technology Park in Jiangsu, as reported by the company through a relevant fact published by the Alternative Market MAB on 2 July 2015. The subsidiary will develop and distribute biotech assets in the Asian market.
(content in spanish)
La compañía española Bionaturis (BME: BNT) ha alcanzado un acuerdo con el Comité Administrativa de la Zona de Desarrollo Industrial de Alta Tecnología de la ciudad de Jiangsu para albergar una filial en el Parque Universitario de Ciencia y Tecnología de la región de Jiangsu, según ha comunciado la propia compañía en un Hecho Relevante remitido al Mercado Alternativo Bursátil (MAB) el 2 de julio de 2015. La filial se dedicará al desarrollo y distribución de activos biotecnológicos en el mercado asiático. |
| Intel ID | 226795 | ||
| Value | ND | ||
| Native Currency | Euro (EUR) | ||
|
Financial Data - Bionaturis
(31 Dec 2022) |
Revenue: EUR 3,37m EBITDA: EUR 0,42m Net Debt: EUR 152,58m People: 34 |
||
| Date |
|
||
| Country | ![]() |
||
| Region | |||
| Continent | ![]() |
||
| Geography | ![]() |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | ![]() |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.01 Biopharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.
